193 related articles for article (PubMed ID: 3466165)
1. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
Scanlon KJ; Newman EM; Lu Y; Priest DG
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8923-5. PubMed ID: 3466165
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo.
Scanlon KJ; Lu Y; Kashani-Sabet M; Ma J; Newman E
Adv Exp Med Biol; 1988; 244():127-35. PubMed ID: 3247881
[TBL] [Abstract][Full Text] [Related]
3. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
Berger SH; Hakala MT
Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
[TBL] [Abstract][Full Text] [Related]
4. Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft.
Radparvar S; Houghton PJ; Houghton JA
Biochem Pharmacol; 1989 Jan; 38(2):335-42. PubMed ID: 2914018
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
6. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Fujiwara Y; Saijo N
Cancer Chemother Pharmacol; 1992; 30(6):417-22. PubMed ID: 1327567
[TBL] [Abstract][Full Text] [Related]
7. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
Johnston PG; Geoffrey F; Drake J; Voeller D; Grem JL; Allegra CJ
Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin.
Newman EM; Lu Y; Kashani-Sabet M; Kesavan V; Scanlon KJ
Biochem Pharmacol; 1988 Feb; 37(3):443-7. PubMed ID: 3337743
[TBL] [Abstract][Full Text] [Related]
9. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
Grem JL; Fischer PH
Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase-catalyzed, tetrahydrofolate-dependent self-inactivation by 5-FdUMP.
Sobich J; Prokopowicz M; Maj P; Wilk P; Zieliński Z; Frączyk T; Rode W
Arch Biochem Biophys; 2019 Oct; 674():108106. PubMed ID: 31520592
[TBL] [Abstract][Full Text] [Related]
11. Phosphorus-31 nuclear magnetic resonance studies of complexes of thymidylate synthase.
Connick TJ; Reilly RT; Dunlap RB; Ellis PD
Biochim Biophys Acta; 1994 Sep; 1208(1):118-26. PubMed ID: 8086425
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P; Bertino JR
Biochem Pharmacol; 1987 Sep; 36(18):2905-11. PubMed ID: 2958010
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to fluoropyrimidines.
Zhang ZG; Harstrick A; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
[TBL] [Abstract][Full Text] [Related]
14. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
Chen TL; Erlichman C
Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
[TBL] [Abstract][Full Text] [Related]
15. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
[TBL] [Abstract][Full Text] [Related]
16. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
Bertino JR; Mini E; Fernandes DJ
Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
[TBL] [Abstract][Full Text] [Related]
17. The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts.
Houghton JA; Schmidt C; Houghton PJ
Eur J Cancer Clin Oncol; 1982 Apr; 18(4):347-54. PubMed ID: 6889511
[TBL] [Abstract][Full Text] [Related]
18. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo.
Shirasaka T; Shimamoto Y; Ohshimo H; Saito H; Fukushima M
Cancer Chemother Pharmacol; 1993; 32(3):167-72. PubMed ID: 8500219
[TBL] [Abstract][Full Text] [Related]
19. 5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates.
Fernandes DJ; Bertino JR
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5663-7. PubMed ID: 6160578
[TBL] [Abstract][Full Text] [Related]
20. Studies of 5-fluorodeoxyuridine 5'-monophosphate binding to carboxypeptidase A-inactivated thymidylate synthase from Lactobacillus casei.
Cisneros RJ; Zapf JW; Dunlap RB
J Biol Chem; 1993 May; 268(14):10102-8. PubMed ID: 8486679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
